Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | GLA | P06280 | 1/20 | 0.63 |
| ▸ | GAA | P10253 | 4/20 | 0.62 |
| ▸ | HPGD | P15428 | 4/20 | 0.59 |
| ▸ | PTGDR2 | Q9Y5Y4 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | JAK2 | O60674 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1375092 | 0.98 | L3MBTL1 (0.61) | L3MBTL1SMN1; SMN2POLBGLAGAA | |
| SCHEMBL29682135 | 0.87 | L3MBTL1 (0.80) | L3MBTL1SMN1; SMN2POLBGLAHPGD | |
| SCHEMBL340762 | 0.87 | L3MBTL1 (0.80) | L3MBTL1SMN1; SMN2POLBGLAHPGD | |
| SCHEMBL7784463 | 0.86 | KDM4E (0.58) | L3MBTL1SMN1; SMN2POLBGLAGAA | |
| Ammonia Solution, Strong SCHEMBL28240461 | 0.85 | L3MBTL1 (0.77) | L3MBTL1SMN1; SMN2POLBGLAHPGD | |
| SCHEMBL9787116 | 0.82 | L3MBTL1 (0.65) | L3MBTL1SMN1; SMN2GAAHPGDALDH1A1 | |
| SCHEMBL1270505 | 0.82 | ALOX15 (0.61) | L3MBTL1SMN1; SMN2POLBGLAALDH1A1 | |
| SCHEMBL10971331 | 0.82 | GAA (0.56) | L3MBTL1SMN1; SMN2POLBGLAGAA | |
| SCHEMBL2391353 | 0.82 | GAA (0.56) | L3MBTL1SMN1; SMN2POLBGLAGAA | |
| SCHEMBL1933278 | 0.82 | GAA (0.63) | L3MBTL1SMN1; SMN2POLBGAAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2992041-A1 | METHODS FOR TREATING LIGNOCELLULOSIC MATERIALS | Virdia, Inc. (US) | 2016-03-09 | — | — | EP | claimed |
| WO-2014178911-A1 | METHODS FOR TREATING LIGNOCELLULOSIC MATERIALS | VIRDIA, INC. (US) | 2014-11-06 | — | — | WO | claimed |
| US-20080108115-A1 | ENHANCED PRODUCTION OF TAXOL AND TAXANES BY CELL CULTURES OF TAXUS SPECIES | DFB BIOTECH, INCORPORATED (US) | 2008-05-08 | — | — | US | claimed |
| US-7264951-B1 | Enhanced production of taxol and taxanes by cell cultures of Taxus species | PHYTON, INC. (US) | 2007-09-04 | — | — | US | claimed |
| WO-2003097857-A2 | METHOD FOR THE DETECTION OF AQUARETIC COMPOUNDS | ZEALAND PHARMA A/S (DK) | 2003-11-27 | — | — | WO | claimed |
| EP-0608779-A1 | Apparatus for peptide synthesis | SHIMADZU CORPORATION (JP) | 1994-08-03 | — | — | EP | claimed |
| EP-0031561-B1 | A RECTALLY ADMINISTERED SUPPOSITORY COMPRISING A DRUG AND AN ADJUVANT | MERCK & CO. INC. (US) | 1985-04-10 | — | — | EP | claimed |
| US-12599649-B2 | Bioactive polypeptides for improvements in plant protection, growth and productivity | SPOGEN BIOTECH INC. (US) | 2026-04-14 | — | — | US | disclosed |
| US-20250388604-A1 | Compounds and Their Use as PDE4 Activators | MIRONID LIMITED (GB) | 2025-12-25 | — | — | US | disclosed |
| US-20250351825-A1 | AGRICULTURAL COMPOSITIONS FOR PROTECTING PLANTS AGAINST ABIOTIC STRESSORS | SPOGEN BIOTECH INC (US) | 2025-11-20 | — | — | US | disclosed |
| US-20250324980-A1 | COMPOSITIONS FOR DELIVERY OF AGENTS INTO PLANT CELLS | OHIO STATE INNOVATION FOUNDATION (US) | 2025-10-23 | — | — | US | disclosed |
| US-12429417-B2 | Devices, systems, and methods for agrochemical detection and agrochemical compositions | SPOGEN BIOTECH, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| US-20250241300-A1 | AGRICULTURAL COMPOSITIONS FOR IMPROVED CROP PRODUCTIVITY AND ENHANCED PHENOTYPES | SPOGEN BIOTECH INC. | 2025-07-31 | — | — | US | disclosed |
| WO-1989003378-A1 | PROCESS FOR THE PREPARATION OF ARYLOXYACETIC ACID | EASTMAN KODAK COMPANY (US) | 1989-04-20 | — | — | WO | disclosed |
| US-4804777-A | OXIDATION OF ARYLOXYETHANOL USING PALLADIUM, SILVER, CARBON CATALYST | EASTMAN KODAK COMPANY (US) | 1989-02-14 | — | — | US | disclosed |
| US-4791224-A | Process for preparation of an oxyacetic acid/hydroxyethyl ether compound | EASTMAN KODAK COMPANY (US) | 1988-12-13 | — | — | US | disclosed |
| US-4731466-A | FUNGICIDES | THE DOW CHEMICAL COMPANY (US) | 1988-03-15 | — | — | US | disclosed |
| EP-0248213-A2 | Hydroxyphenyl- and hydroxyphenoxyalkanoic acid iodopropargyl esters | THE DOW CHEMICAL COMPANY (US) | 1987-12-09 | — | — | EP | disclosed |
| EP-0159864-A2 | Method of modifying taste | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1985-10-30 | — | — | EP | disclosed |
| US-3944560-A | BRONCHODILATOR | MERCK & CO., INC. (US) | 1976-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12599649-B2 | Bioactive polypeptides for improvements in plant protection, growth and productivity | MAX, VIP, MRTO4 | L3MBTL1 271/4885SMN1; SMN2 3758/4885POLB 1773/4885 |
| US-20250324980-A1 | COMPOSITIONS FOR DELIVERY OF AGENTS INTO PLANT CELLS | ARGLU1, PHAX, VMA21 | L3MBTL1 865/4885SMN1; SMN2 4524/4885POLB 4407/4885 |
| US-20250388604-A1 | Compounds and Their Use as PDE4 Activators | PDE4A, PDE7A, PDE4B | L3MBTL1 3716/4885SMN1; SMN2 1015/4885POLB 773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.